864858-33-3

Upstream product

• 155345-99-6 (1S,2R,3S,5S)-7,7-dimethyl-4,6,8-trioxa-3-[(phenylmethoxy)methyl]bicyclo[3.3.0]octan-2-ol 
• 864858-18-4 5-O-benzyl-1,2-O-isopropylidene-3-O-triflyl-α-L-xylofuranose 
• 864858-24-2 [(3aS,4aS,5aS,5bS)-2,2-dimethyltetrahydro-4aH-cyclopropa[4,5]furo[2,3-d][1,3]dioxol-4a-yl]methyl benzyl ether 
• 864858-27-5 (1S,3S,4S,5S)-1-[(benzyloxy)methyl]-3-methoxy-2-oxabicyclo[3.1.0]hexan-4-ol 
• 864858-21-9 [(3aS,6aS)-2,2-dimethyl-3a,6a-dihydrofuro[2,3-d][1,3]dioxol-5-yl]methyl benzyl ether 
• 864858-30-0 (1S,3S,4R,5S)-1-[(benzyloxy)methyl]-3-methoxy-2-oxabicyclo[3.1.0]hexan-4-ol 
• 108-24-7 acetic anhydride 

Relevant academic research and scientific papers

Synthesis and study of conformationally restricted 3′-deoxy-3′, 4′-exo-methylene nucleoside analogues

Hitherto unknown restricted 3′-deoxy-3′,4′-exo-methylene nucleoside derivatives bearing the nucleic acid naturally occurring pyrimidine bases have been synthesized. The compounds were tested for their activity against HIV, HBV, and several RNA viruses, bu

Synthesis of nucleoside analogues bearing the five naturally occurring nucleic acid bases built on a 2-oxabicylo[3.1.0]hexane scaffold

Hitherto unknown nucleoside analogues incorporating the five naturally occurring nucleic acid bases built on a 2-oxabicyclo[3.1.0]hexane template were synthesized. The synthesis of these new conformationally restricted nucleoside analogues involved the pr